mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.01 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.01 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.02 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.02 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |